FDA Inspects Five Sabinsa Facilities
Sabinsa says the agency found a minor, now-corrected issue at one of the facilities.
FDA has inspected five of Sabinsa Corp.’s SAMI Labs manufacturing facilities in India, finding minor issue with just one of those facilities, as Sabinsa explains:
“The issue involved a polyliner becoming tangled in the conveyer belts leading to the extraction chamber; corrective action included changing to HDPE bags without lining and improving hopper and mesh at the point of feeding raw material into the extraction equipment.”
The inspected facilities were located in Kunigal, Nelamangala, and Dobaspet (Karnataka), and Genome Valley, Hyderabad.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
